A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours
| Image |  |
|---|---|
| Description | scientific article published on 25 August 2020 |
| Author/s |
author: Christophe Le Tourneau Anne Vincent-Salomon Philippe Alexandre Cassier |
| Publication date | August 25, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |